Ubs Asset Management Americas Inc Intercept Pharmaceuticals, Inc. Transaction History

Ubs Asset Management Americas Inc

$345 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$12.53 - $21.71 $46,924 - $81,303	-3,745 Reduced 13.58%	23,834 $320,000
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $173,546 - $240,812	14,948 Added 118.34%	27,579 $341,000
Q3 2022 Nov 14, 2022	SELL	$12.21 - $19.7 $131,770 - $212,602	-10,792 Reduced 46.07%	12,631 $176,000
Q2 2022 Aug 12, 2022	SELL	$11.23 - $19.59 $18,933 - $33,028	-1,686 Reduced 6.71%	23,423 $323,000
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $192,909 - $305,711	12,478 Added 98.79%	25,109 $501,000
Q4 2020 Mar 01, 2021	SELL	$24.48 - $42.47 $3.62 Million - $6.28 Million	-147,885 Reduced 92.13%	12,631 $311,000
Q3 2020 Nov 13, 2020	SELL	$39.09 - $53.44 $224,767 - $307,280	-5,750 Reduced 3.46%	160,516 $6.65 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $104,748 - $206,445	-2,243 Reduced 1.33%	166,266 $7.97 Million
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $710,551 - $1.74 Million	-14,696 Reduced 8.02%	168,509 $10.6 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $1.38 Million - $2.99 Million	24,066 Added 15.12%	183,205 $22.7 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $123,131 - $168,805	2,098 Added 1.34%	159,139 $10.6 Million
Q2 2019 Aug 15, 2019	BUY	$77.77 - $120.68 $4.75 Million - $7.36 Million	61,017 Added 63.54%	157,041 $0
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $270,531 - $355,523	2,946 Added 3.17%	96,024 $0
Q4 2018 Feb 13, 2019	SELL	$85.79 - $126.46 $1.98 Million - $2.91 Million	-23,037 Reduced 19.84%	93,078 $9.38 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $9.36 Million - $13.5 Million	105,719 Added 1016.92%	116,115 $0
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $42,960 - $61,339	716 Added 7.4%	10,396 $0
Q4 2017 Feb 09, 2018	BUY	$58.2 - $72.76 $26,481 - $33,105	455 Added 4.93%	9,680 $0
Q3 2017 Nov 13, 2017	BUY	$57.01 - $118.75 $525,917 - $1.1 Million	9,225	9,225 $0

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account